Literature DB >> 3127152

Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel.

S H Xiao, W J Yue, Y Q Yang, J Q You.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3127152

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  35 in total

Review 1.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum.

Authors:  Shu-hua Xiao; Jing-yan Mei; Pei-ying Jiao
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

3.  Schistosoma japonicum-infected hamsters (Mesocricetus auratus) used as a model in experimental chemotherapy with praziquantel, artemether, and OZ compounds.

Authors:  Shu-hua Xiao; Jing-yan Mei; Pei-ying Jiao
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

4.  Further observation on histopathological alterations of adult Schistosoma japonicum harbored in mice following treatment with mefloquine at a smaller single dose.

Authors:  Shu-Hua Xiao; Chao-Wei Zhang
Journal:  Parasitol Res       Date:  2010-06-08       Impact factor: 2.289

Review 5.  Schistosomiasis--a century searching for chemotherapeutic drugs.

Authors:  Gabriela Ribeiro-dos-Santos; Sergio Verjovski-Almeida; Luciana C C Leite
Journal:  Parasitol Res       Date:  2006-04-25       Impact factor: 2.289

6.  Transmission electron microscopic observation on ultrastructural alterations in Schistosoma japonicum caused by mefloquine.

Authors:  Shu-hua Xiao; Jian Xue; Binggui Shen
Journal:  Parasitol Res       Date:  2010-02-20       Impact factor: 2.289

7.  Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice.

Authors:  Hong-jun Li; Wei Wang; Guo-li Qu; You-zi Li; Yong-hui Tao; Yun-tian Xing; Xiao-ting Wang; Yang Dai; Jian-ying Wei; Jian-rong Dai; Gerald C Coles; You-sheng Liang
Journal:  Parasitol Res       Date:  2011-10-18       Impact factor: 2.289

8.  Ultrastructural alterations of juvenile Schistosoma japonicum harbored in mice following mefloquine administration.

Authors:  Shu-Hua Xiao; Jun Sun; Jian Xue; Xi-Ling Du; Hao-Bing Zhang
Journal:  Parasitol Res       Date:  2011-07-13       Impact factor: 2.289

Review 9.  New insight into praziquantel against various developmental stages of schistosomes.

Authors:  Wei Wu; Wei Wang; Yi-Xin Huang
Journal:  Parasitol Res       Date:  2011-10-08       Impact factor: 2.289

10.  In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species.

Authors:  Shu-Hua Xiao; Jennifer Keiser; Jacques Chollet; Jürg Utzinger; Yuxiang Dong; Yvette Endriss; Jonathan L Vennerstrom; Marcel Tanner
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.